SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 121 filers reported holding SERES THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,451 | -54.8% | 16,156 | -9.1% | 0.02% | -54.0% |
| Q2 2023 | $85,109 | -8.2% | 17,768 | +8.7% | 0.05% | -2.0% |
| Q1 2023 | $92,665 | -26.9% | 16,343 | -27.8% | 0.05% | -22.7% |
| Q4 2022 | $126,717 | -48.9% | 22,628 | -41.5% | 0.07% | -33.3% |
| Q3 2022 | $248,000 | +87.9% | 38,694 | +0.7% | 0.10% | +102.0% |
| Q2 2022 | $132,000 | -3.6% | 38,407 | +99.6% | 0.05% | -19.7% |
| Q1 2022 | $137,000 | -19.4% | 19,245 | -5.6% | 0.06% | -4.7% |
| Q4 2021 | $170,000 | +136.1% | 20,379 | +98.0% | 0.06% | +100.0% |
| Q3 2021 | $72,000 | -72.1% | 10,292 | -4.9% | 0.03% | -69.8% |
| Q2 2021 | $258,000 | +3.6% | 10,827 | -10.5% | 0.11% | +1.0% |
| Q1 2021 | $249,000 | -14.4% | 12,095 | +1.7% | 0.10% | -13.2% |
| Q4 2020 | $291,000 | -48.3% | 11,891 | -84.5% | 0.12% | -75.2% |
| Q1 2018 | $563,000 | +57.3% | 76,713 | +117.3% | 0.49% | +8.7% |
| Q4 2017 | $358,000 | -30.9% | 35,295 | +9.4% | 0.45% | +541.4% |
| Q3 2017 | $518,000 | +56.5% | 32,276 | +10.1% | 0.07% | +42.9% |
| Q2 2017 | $331,000 | -5.7% | 29,324 | -5.8% | 0.05% | -22.2% |
| Q1 2017 | $351,000 | +25.8% | 31,133 | +10.6% | 0.06% | -24.1% |
| Q4 2016 | $279,000 | +179.0% | 28,148 | +247.6% | 0.08% | +72.9% |
| Q3 2016 | $100,000 | -57.4% | 8,098 | 0.0% | 0.05% | -72.4% |
| Q2 2016 | $235,000 | +34.3% | 8,098 | +23.1% | 0.17% | -27.8% |
| Q1 2016 | $175,000 | – | 6,580 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |